The reduced bioavailability of NO induces the production and release of endothelium-derived vasoconstrictor prostanoids and endothelin-1 [54], leading to vasoconstriction which amplifies the degree of endothelial dysfunction. Here, EDN1 is linked to endothelial dysfunction.